Elon Musk might have his eyes set on Mars, but he says people should also be open to exploring internally with psychedelics.
The SpaceX founder also predicted that, as younger generations assume positions of power in government, there will be a greater societal embrace of the therapeutic potential of psychedelics.
Musk was asked about the issue during a panel event at CodeCon on Tuesday. Citing the entrepreneur’s past comments on DMT, Field Trip co-founder Ronan Levy asked “what role you think psychedelics may have in addressing some of the more destructive tendencies of humanity.”
“I think, generally, people should be open to psychedelics,” Musk said. “A lot of people making laws are kind of from a different era, so I think, as the new generation gets into political power, I think we will see greater receptivity to the benefits of psychedelics.”
While Musk is encouraging open-mindedness on psychedelics, he said earlier this year during an appearance on Joe Rogan’s podcast that he feels CBD from cannabis is overhyped and “doesn’t do anything.”
That exchange started with Musk and Rogan reflecting on an earlier podcast show in 2018, where the SpaceX and Tesla CEO puffed on a marijuana blunt (which he later claimed he never actually inhaled), prompting an investigation by NASA over his aerospace company’s “workplace safety” and “adherence to a drug-free environment.”
— Ronan Levy (@RonanDLevy) September 29, 2021
Musk might not be on-board with CBD, but he does enjoy playing into marijuana culture from time to time.
When shares of Telsa hit $420, for example, he responded on Twitter with crying laughing emojis and said “Whoa … the stock is so high lol.”
Of course, 420 is well known among cannabis enthusiasts, as it represents the unofficial cannabis holiday, 4/20. And that wasn’t the first time that Musk has played into it, either.
The billionaire tech entrepreneur landed in hot water with the Securities and Exchange Commission in 2018 after he said he was considering taking Tesla private at a share price of $420—an announcement that SEC described as “false and misleading” and that was made without required notification to regulators.